Purple Biotech Q1 2025 Earnings DevelopmentStage Focus Drives Investor Sentiment NXT Q1 2026 Earnings EPS Surprises 1316 Above Estimates KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Navigates Development AZTR Q1 2026 Earnings Significant EPS Miss and Stock Decline Amid PreRevenue Stage SMR Q1 2026 Earnings WiderThanExpected Loss Amid PreRevenue Stage Stock Barely Moves ARW Q1 2026 Earnings Massive EPS Beat of 81 but Stock Slides Slightly